ResVita Bio Receives Rare Pediatric Disease Designation for RVB-001 as a Treatment for Netherton Syndrome
https://www.prnewswire.com/news-releases/resvita-bio-receives-rare-pediatric-disease-designation-for-rvb-001-as-a-treatment-for-netherton-syndrome-301563562.html
© 2022 Regents of the University of California. All Rights Reserved.